ALLO — ALLOGENE THERAPEUTICS INC
As of Q2 2026, 27 SEC-registered investment managers reported holding ALLO (ALLOGENE THERAPEUTICS INC) in their latest 13F filings, with a combined reported value of $238.22M across 119.06M shares. That is +68.8% by share count (+48.52M shares) versus the previous quarter, while reported value moved +49.8%. Ownership is concentrated: the five largest holders account for 58.7% of reported value and the top ten for 80.8%.
Compared with the prior quarter, 2 opened new positions, 22 added to existing stakes, 3 trimmed, 3 exited entirely. 13F holdings are quarter-end snapshots, so these moves reflect positioning as of Q2 2026, not real-time trading.
ALLO is classified in the Health Care sector.
All figures on this page are computed from SEC Form 13F quarterly filings. 13F filers disclose long positions of $100,000 or more within 45 days of quarter end; short positions, options overlays and intra-quarter trades are not included, so treat the numbers as a quarterly snapshot of institutional ownership rather than real-time positioning.
| Fund | Quarter | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|---|
| Capital Research Global Investors history | Q3 2021 | 5.40M | $138.89M | 0.03% | New |
| BlackRock Inc history | Q2 2026 | 30.15M | $62.71M | 0.00% | Add |
| Casdin Capital history | Q4 2021 | 2.65M | $39.54M | 1.13% | Add |
| Fidelity Management & Research (FMR) history | Q2 2026 | 12.01M | $24.98M | 0.00% | Add |
| Citadel Advisors history | Q2 2026 | 10.22M | $21.26M | 0.00% | Add |
| Two Sigma Investments history | Q2 2026 | 7.78M | $16.19M | 0.01% | Add |
| Geode Capital Management history | Q2 2026 | 7.05M | $14.67M | 0.00% | Add |
| Goldman Sachs Group history | Q2 2026 | 6.15M | $12.79M | 0.00% | Add |
| Vanguard Group history | Q4 2025 | 9.25M | $12.67M | 0.00% | Add |
| Capital World Investors history | Q2 2025 | 11.15M | $12.60M | 0.00% | Reduce |
| Marshall Wace history | Q2 2026 | 5.10M | $10.60M | 0.01% | Add |
| Millennium Management history | Q2 2026 | 4.84M | $10.08M | 0.00% | Add |
| D. E. Shaw & Co history | Q2 2026 | 4.71M | $9.80M | 0.01% | Add |
| Morgan Stanley history | Q2 2026 | 4.51M | $9.38M | 0.00% | Add |
| Renaissance Technologies history | Q2 2026 | 3.83M | $7.98M | 0.01% | Add |
| Bank of America Corp history | Q2 2026 | 3.19M | $6.63M | 0.00% | Add |
| UBS Group AG history | Q2 2026 | 3.04M | $6.32M | 0.00% | Add |
| Northern Trust Corp history | Q2 2026 | 2.96M | $6.15M | 0.00% | Add |
| Charles Schwab Investment Management history | Q2 2026 | 2.27M | $4.73M | 0.00% | Add |
| AQR Capital Management history | Q2 2026 | 2.01M | $4.17M | 0.00% | Reduce |
New Positions (Q2 2026)
- JPMorgan Chase & Co 1.44M sh · $3.19M
- CPP Investments 115.50K sh · $240.24K
Fully Exited (vs previous quarter)
- Balyasny Asset Management sold 1.18M sh · $2.89M
- Point72 Asset Management sold 221.34K sh · $540.06K
- PNC Financial Services sold 3.06K sh · $7.46K
Fund Position History — shares by quarter (top 20 funds)
| Fund | Q3 2021 | Q4 2021 | Q1 2022 | Q2 2022 | Q3 2022 | Q4 2022 | Q1 2023 | Q2 2023 | Q3 2023 | Q4 2023 | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | Q1 2026 | Q2 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| BlackRock Inc | — | — | — | — | — | — | — | — | — | — | — | — | 17.77M | 18.06M | 17.93M | 17.90M | 17.51M | 17.68M | 19.09M | 30.15M |
| Fidelity Management & Research (FMR) | 909.25K | 1.88M | 1.12M | 1.32M | 1.23M | 1.56M | 1.37M | 24.92M | 25.14M | 25.24M | 25.36M | 31.26M | 30.03M | 23.77M | 7.39M | 983.00K | 710.96K | 1.45M | 1.59M | 12.01M |
| Citadel Advisors | 348.01K | 2.45M | 2.66M | 104.56K | 934.96K | 571.20K | 4.39M | 4.79M | 4.16M | 4.11M | 3.13M | 2.50M | 5.08M | 5.42M | 10.30M | 10.35M | 14.02M | 12.21M | 6.89M | 10.22M |
| Two Sigma Investments | — | 189.79K | 954.16K | 159.08K | 832.96K | 1.61M | 1.88M | 1.95M | 1.30M | 2.31M | 1.91M | 2.96M | 2.80M | 2.71M | 2.08M | 1.61M | 3.38M | 3.42M | 5.38M | 7.78M |
| Geode Capital Management | 1.26M | 1.38M | 1.26M | 1.47M | 1.63M | 1.71M | 1.75M | 1.83M | 2.07M | 2.34M | 2.37M | 2.82M | 3.23M | 3.23M | 3.36M | 3.79M | 3.83M | 3.93M | 4.12M | 7.05M |
| Goldman Sachs Group | 1.98M | 1.82M | 2.96M | 1.97M | 2.40M | 1.62M | 1.15M | 1.50M | 1.41M | 3.34M | 1.29M | 1.53M | 2.16M | 2.11M | 5.85M | 5.50M | 1.20M | 2.29M | 2.77M | 6.15M |
| Marshall Wace | — | 948.62K | — | — | 12.59K | — | 435.02K | 43.35K | 228.64K | — | — | — | — | — | — | — | — | 285.56K | 3.45M | 5.10M |
| Millennium Management | 228.62K | 155.03K | 571.21K | 776.87K | 1.40M | 3.28M | 1.00M | 209.77K | 124.40K | 1.92M | 201.47K | 179.62K | 258.00K | — | 256.85K | 1.50M | 3.39M | 1.84M | 3.32M | 4.84M |
| D. E. Shaw & Co | 22.71K | 529.82K | 985.10K | 283.69K | 439.69K | 660.19K | 512.68K | 275.85K | 124.24K | 75.64K | 195.78K | 240.25K | 90.33K | 54.52K | — | — | 463.90K | 1.28M | 2.76M | 4.71M |
| Morgan Stanley | 1.06M | 1.27M | 1.69M | 1.14M | 616.02K | 850.48K | 981.48K | 1.33M | 1.38M | 1.67M | 2.23M | 2.16M | 1.72M | 998.60K | 2.35M | 608.97K | 1.30M | 703.14K | 998.85K | 4.51M |
| Renaissance Technologies | — | — | 974.70K | — | — | 440.10K | 428.70K | 251.90K | 30.28K | 458.65K | 396.90K | 1.75M | 642.01K | 554.54K | 1.56M | 1.67M | 2.89M | 2.19M | 2.14M | 3.83M |
| Bank of America Corp | 57.87K | 269.63K | 579.93K | 267.99K | 363.66K | 864.48K | 1.03M | 715.47K | 836.47K | 330.89K | 404.38K | 432.70K | 583.92K | 1.16M | 948.81K | 987.50K | 974.32K | 1.01M | 2.13M | 3.19M |
| UBS Group AG | 172.51K | 157.74K | 222.87K | 137.27K | 181.48K | 135.88K | 232.51K | 297.01K | 206.76K | 181.19K | 519.20K | 300.32K | 347.34K | 796.49K | 2.14M | 2.04M | 3.57M | 1.39M | 1.60M | 3.04M |
| Northern Trust Corp | 713.50K | 724.72K | 699.08K | 752.31K | 1.17M | 830.40K | 799.17K | 862.51K | 860.53K | 1.01M | 971.07K | 1.04M | 1.25M | 1.31M | 1.19M | 1.27M | 1.28M | 1.20M | 1.29M | 2.96M |
| Charles Schwab Investment Management | 531.00K | 537.04K | 530.66K | 544.11K | 635.46K | 648.79K | 650.28K | 665.33K | 781.33K | 732.84K | 858.48K | 1.18M | 1.18M | 1.19M | 1.16M | 1.23M | 1.17M | 1.36M | 1.40M | 2.27M |
| AQR Capital Management | 20.29K | 28.89K | 73.72K | — | — | — | — | — | — | — | — | 27.29K | 33.59K | — | 58.22K | 80.62K | 1.85M | 1.43M | 2.48M | 2.01M |
| JPMorgan Chase & Co | 3.32M | 3.62M | 3.56M | 4.50M | 3.97M | 3.77M | 4.92M | 6.13M | 6.91M | 6.91M | 5.18M | 4.12M | 4.09M | 3.74M | 5.14M | 934.02K | 908.73K | 979.11K | — | 1.44M |
| Invesco Ltd | 35.11K | 37.20K | 82.55K | 598.16K | 90.19K | 89.81K | 95.01K | 92.27K | 93.51K | 101.98K | 120.68K | 120.14K | 119.13K | 127.49K | 285.21K | 396.51K | 525.31K | 609.81K | 684.52K | 772.79K |
| BNY Mellon | 318.81K | 298.68K | 299.25K | 248.38K | 288.52K | 308.42K | 350.17K | 308.89K | 310.81K | 323.98K | 300.55K | 362.36K | 317.62K | 330.77K | 331.19K | 375.04K | 401.87K | 405.84K | 395.19K | 727.18K |
| Citigroup Inc | 126.66K | 265.38K | 119.17K | 240.97K | 517.79K | 344.37K | 555.34K | 281.36K | 338.76K | 34.32K | 678.23K | 75.17K | 469.31K | 716.24K | 688.52K | 642.54K | 594.10K | 591.95K | 353.33K | 515.50K |
▲ Bought Low (fund opened/added, stock rose ≥5% next quarter) ▼ Sold High (fund reduced, stock fell ≥5% next quarter)
Drag / scroll to zoom · Default shows the most recent year · Annotations come from quarterly fund actions in 13F filings · Hover a marker for details